meglumine antimoniate has been researched along with Neglected Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Alves, MLR; Bandeira, CC; de Faria, BG; Giunchetti, RC; Peruhype-Magalhães, V; Ribeiro, JM; Souza-Fagundes, EM; Teixeira-Carvalho, A; Uzonna, JE; Vieira, FO | 1 |
| Bari, AU; Khan, NH | 1 |
| Alonso, S; Laamrani El Idrissi, A; Najdi, A; Nejjari, C; Picado, A; Sicuri, E; Tachfouti, N | 1 |
3 other study(ies) available for meglumine antimoniate and Neglected Diseases
| Article | Year |
|---|---|
An ex vivo multiparametric flow cytometry assay using human whole blood to simultaneously measure cytotoxicity and leishmanicidal activities.
Topics: Adult; Amphotericin B; Animal Testing Alternatives; Animals; Antiprotozoal Agents; Drug Discovery; Drug Evaluation, Preclinical; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Leishmania; Leishmania braziliensis; Leishmaniasis; Leukocytes; Meglumine Antimoniate; Microscopy, Confocal; Middle Aged; Monocytes; Neglected Diseases; Time Factors; Young Adult | 2020 |
Cutaneous Leishmaniasis caused by L. Infantum.
Topics: Adult; Animals; Female; Humans; Injections, Intralesional; Leishmania infantum; Leishmaniasis, Cutaneous; Male; Meglumine Antimoniate; Middle Aged; Neglected Diseases; Polymerase Chain Reaction; Treatment Outcome | 2019 |
Cost of Pediatric Visceral Leishmaniasis Care in Morocco.
Topics: Antiprotozoal Agents; Child; Child, Preschool; Cost of Illness; Female; Health Care Costs; Humans; Infant; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Morocco; Neglected Diseases; Organometallic Compounds | 2016 |